Page last updated: 2024-10-20

thiamine and 2019 Novel Coronavirus Disease

thiamine has been researched along with 2019 Novel Coronavirus Disease in 12 studies

thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.

Research Excerpts

ExcerptRelevanceReference
"In sub-Saharan Africa, the COVID-19 pandemic has caused severe malnutrition in elderly populations with the appearance of vitamin deficiencies, in particular thiamine responsible for Gayet Wernicke's encephalopathy (EGW)."4.31GAYET WERNICKE'S ENCEPHALOPATHY AFTER COVID-19 IN ELDERLY SUBJECTS IN TROPICAL ENVIRONMENTS: STUDY OF SIX (6) OBSERVATIONS IN CONAKRY. ( Camara, D; Cisse, A; Cisse, FA; Condé, K; Conde, S; Diakité, M; Diallo, MS; Diallo, SM; Kadji, JM; Kassa, DF; Lamah, E; Millimono, V; Othon, GC; Sakadi, F; Touré, A; Touré, ML, 2023)
"Clinicopathological characteristics, frailty assessment, biochemical and micronutrient laboratory results were recorded."1.91The relationship between micronutrient status, frailty, systemic inflammation, and clinical outcomes in patients admitted to hospital with COVID-19. ( Barbour, K; Brice, K; Catchpole, A; Goodall, E; Kelliher, T; Kemp, O; Maguire, D; McGovern, J; McMillan, DC; McPhillips, S; Melaugh, T; Moffitt, P; Murray, E; Richards, C; Robinson, S; Talwar, D; Wadsworth, J, 2023)
"Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases."1.62Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study. ( Al Bekairy, AM; Al Dossari, M; Al Eidan, F; Al Ghamdi, G; Al Harbi, S; Al Jeraisy, M; Al Katheri, A; Al Muqrin, M; Al Qahtani, N; Al Sulaiman, K; Algarni, R; Alharbi, A; Aljuhani, O; Alshahrani, A; Vishwakarma, R, 2021)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's12 (100.00)2.80

Authors

AuthorsStudies
Al-Anezi, A1
Sotirova-Koulli, V1
Shalaby, O1
Ibrahim, A1
Abdulmotagalli, N1
Youssef, R1
Hossam El-Din, M1
Chehayeb, RJ1
Ilagan-Ying, YC1
Sankey, C1
Touré, ML1
Othon, GC1
Touré, A1
Diakité, M1
Condé, K1
Kassa, DF1
Sakadi, F1
Camara, D1
Conde, S1
Millimono, V1
Diallo, MS1
Diallo, SM1
Kadji, JM1
Lamah, E1
Cisse, FA1
Cisse, A1
McGovern, J1
Wadsworth, J1
Catchpole, A1
Richards, C1
McMillan, DC1
Kelliher, T1
Goodall, E1
Murray, E1
Melaugh, T1
McPhillips, S1
Brice, K1
Barbour, K1
Robinson, S1
Moffitt, P1
Kemp, O1
Talwar, D1
Maguire, D1
Dhanani, LY1
Totton, RR1
Jara-Quijada, E1
Pérez-Won, M1
Tabilo-Munizaga, G1
Lemus-Mondaca, R1
González-Cavieres, L1
Palma-Acevedo, A1
Herrera-Lavados, C1
Milovanovic, S1
Grzegorczyk, A1
Świątek, Ł1
Grzęda, A1
Dębczak, A1
Tyskiewicz, K1
Konkol, M1
Li, Y2
Chang, P1
Sankaran, S1
Jang, H1
Nie, Y1
Zeng, A1
Hussain, S1
Wu, JY1
Chen, X2
Shi, L2
Senapati, A1
Chetri, BK1
Mitra, S1
Shelke, RG1
Rangan, L1
Chauhan, AS1
Tiwari, M1
Indoliya, Y1
Mishra, SK1
Lavania, UC1
Chauhan, PS1
Chakrabarty, D1
Tripathi, RD1
Akaputra, R1
Hatta, M1
Massi, MN1
Djaharuddin, I1
Bukhari, A1
Aminuddin, A1
Santoso, A1
Natzir, R1
Bahar, B1
Fachri, M1
Farsida, F1
Fathimah, A1
Ubaidah, FM1
Sridiana, E1
Dwiyanti, R1
Syukri, A1
Junita, AR1
Febrianti, A1
Primaguna, MR1
Azhar, A1
Rajaure, YS1
Thapa, B1
Budhathoki, L1
Rana, SR1
Khadka, M1
Batchu, UR1
Surapaneni, JR1
Cheemalamarri, C1
Mandava, K1
Puvvada, N1
Shetty, PR1
Mv, S1
Ranjbarian, P1
Goudarzi, F1
Akya, A1
Heidarinia, H1
Farasat, A1
Rostamian, M1
Suri, K1
Rajput, N1
Sharma, P1
Omble, AD1
Kulkarni, K1
Gahlay, GK1
Fernandez Garcia, E1
Paudel, U1
Noji, MC1
Bowman, CE1
Rustgi, AK1
Pitarresi, JR1
Wellen, KE1
Arany, Z1
Weissenrieder, JS1
Foskett, JK1
Lee, MS1
Han, HJ1
Choi, TI1
Lee, KH1
Baasankhuu, A1
Kim, HT1
Kim, CH1
Redd, PS1
Payero, L1
Gilbert, DM1
Page, CA1
King, R1
McAssey, EV1
Bodie, D1
Diaz, S1
Hancock, CN1
Lee, HS1
Jung, S1
Lee, SW1
Kim, YT1
Lee, J1
Ren, T1
Yu, Z1
Yu, H1
Deng, K1
Wang, Z1
Li, X1
Wang, H1
Wang, L2
Xu, Y1
Lascano, J1
Riley, L1
Khodayari, N1
Brantly, M1
Gupta, R1
Pradhan, J1
Haldar, A1
Murapaka, C1
Chandra Mondal, P1
Gao, R1
Dai, TY1
Meng, Z1
Sun, XF1
Liu, DX1
Shi, MM1
Li, HR1
Kang, X1
Bi, B1
Zhang, YT1
Xu, TW1
Yan, JM1
Jiang, Q1
Helmchen, G1
Guo, H1
Xiang, W1
Fang, Y1
Li, J4
Lin, Y1
An, X1
Jiang, D1
Cao, Q1
Xu, F1
Shiigi, H1
Wang, W1
Chen, Z1
Akosman, I1
Kumar, N1
Mortenson, R1
Lans, A1
De La Garza Ramos, R1
Eleswarapu, A1
Yassari, R1
Fourman, MS1
Jana, S1
Evans, EGB1
Jang, HS1
Zhang, S2
Zhang, H1
Rajca, A1
Gordon, SE1
Zagotta, WN1
Stoll, S1
Mehl, RA1
Miller, S1
Lee, DA1
Muhimpundu, S1
Maxwell, CA1
Liu, Z1
Shen, F1
Tong, Q1
Tang, M1
Peng, M1
Jiao, Z1
Jiang, Y1
Ao, L1
Fu, W1
Lv, X1
Jiang, G1
Hou, L1
Tu, WC1
McManamen, AM1
Su, X1
Jeacopello, I1
Takezawa, MG1
Hieber, DL1
Hassan, GW1
Lee, UN1
Anana, EV1
Locknane, MP1
Stephenson, MW1
Shinkawa, VAM1
Wald, ER1
DeMuri, GP1
Adams, KN1
Berthier, E1
Thongpang, S1
Theberge, AB1
Jiang, L1
Li, Z1
Dong, Q1
Rong, X1
Dong, G1
Huang, J1
Liang, Y1
Sun, S1
Zhang, R1
Miao, Z1
Senju, C1
Nakazawa, Y1
Oso, T1
Shimada, M1
Kato, K1
Matsuse, M1
Tsujimoto, M1
Masaki, T1
Miyazaki, Y1
Fukushima, S1
Tateishi, S1
Utani, A1
Murota, H1
Tanaka, K1
Mitsutake, N1
Moriwaki, S1
Nishigori, C1
Ogi, T1
Liu, C1
Zhang, X1
Wang, B1
Luo, Z1
Qian, D1
Liu, J1
Waterhouse, GIN1
Barbosa, M1
Marques-Sá, J1
Carvalho, C1
Fernandes, V1
Grilli, D1
Smetana, V1
Ahmed, SJ1
Shtender, V1
Pani, M1
Manfrinetti, P1
Mudring, AV1
Kuang, Y1
Yang, D1
Gai, S1
He, F1
An, B1
Yang, P1
Notini, L1
Schulz, K1
Kubeneck, LJ1
Grigg, ARC1
Rothwell, KA1
Fantappiè, G1
ThomasArrigo, LK1
Kretzschmar, R1
Siswanto, FM1
Okukawa, K1
Tamura, A1
Oguro, A1
Imaoka, S1
Kim, CG1
Jung, M1
Kim, HS1
Lee, CK1
Jeung, HC1
Koo, DH1
Bae, WK1
Zang, DY1
Kim, BJ1
Kim, H1
Yun, UJ1
Che, J1
Park, S1
Kim, TS1
Kwon, WS1
Park, J1
Cho, SW1
Nam, CM1
Chung, HC1
Rha, SY1
Colombo, N1
Van Gorp, T1
Matulonis, UA1
Oaknin, A1
Grisham, RN1
Fleming, GF1
Olawaiye, AB1
Nguyen, DD1
Greenstein, AE1
Custodio, JM1
Pashova, HI1
Tudor, IC1
Lorusso, D1
Zhou, F1
Jiang, Z1
Liang, H1
Ru, S1
Bettiol, AA1
Gao, W1
Lipsyc-Sharf, M1
Jain, E1
Collins, LC1
Rosenberg, SM1
Ruddy, KJ1
Tamimi, RM1
Schapira, L1
Come, SE1
Peppercorn, JM1
Borges, VF1
Warner, E1
Snow, C1
Krop, IE1
Kim, D1
Weiss, J1
Zanudo, JGT1
Partridge, AH1
Wagle, N1
Waks, AG1
Moskowitz, A1
Berg, KM1
Grossestreuer, AV1
Balaji, L1
Liu, X1
Cocchi, MN1
Chase, M1
Gong, MN1
Gong, J1
Parikh, SM1
Ngo, L1
Berlin, N1
Donnino, MW1
Zhou, Y1
Chen, Q1
Zhong, S1
Liu, H1
Koh, K1
Chen, H1
He, J1
Chen, J1
Liu, S1
Lin, L1
Zhang, Y1
Xiao, S1
Cao, S1
Yan, B2
Deng, J1
Gu, J1
Tao, Y1
Huang, C1
Lai, C1
Yong, Q1
Shen, Y1
Gong, Z1
Cao, J1
Mao, W1
Yao, Y1
Zhao, J1
Li, Q1
Liu, K1
Liu, B1
Feng, S1
Chandran, V1
Kunjan, C1
Veerapandian, V1
Kannan, R1
Zhang, T1
von Gunten, U1
Caruso, FR1
Goulart, CDL1
Jr, JCB1
de Oliveira, CR1
Mendes, RG1
Arena, R1
Borghi-Silva, A1
Carrasco-Nuñes, N1
Romano, M1
Cabeza, M1
Jiang, B1
Chen, D1
Zhao, C1
Ma, Y1
Yang, W1
Shen, X1
Satheeshkumar, K1
Saravanakumar, P1
Kalavathi, A1
Vennila, KN1
Elango, KP1
Mues Genannt Koers, L1
Prevost, D1
Paulssen, E1
Hoehr, C1
Ulhassan, Z1
Yang, S1
He, D1
Khan, AR1
Salam, A1
Azhar, W1
Muhammad, S1
Ali, S1
Hamid, Y1
Khan, I1
Sheteiwy, MS1
Zhou, W1
Wang, X1
Xie, Q1
Wang, Y1
Lü, H1
Fu, M1
Wang, D1
Marik, PE2
Kory, P2
Varon, J2
Iglesias, J2
Meduri, GU2
Jovic, TH1
Ali, SR1
Ibrahim, N1
Jessop, ZM1
Tarassoli, SP1
Dobbs, TD1
Holford, P1
Thornton, CA1
Whitaker, IS1
Walters, W1
Collins, T1
Evans, A1
Nouira, N1
Mansouri, R1
Tlili, R1
Bhouri, I1
Sfaxi, S1
Chtourou, D1
Cheikh, MB1
Raharimanantsoa, OL1
Razakarivony, FA1
Andriamiadanalisoa, AO1
Rajaona, RA1
Rakotoarisoa, R1
Randrianarimanana, SER1
Raobela, L1
Al Sulaiman, K1
Aljuhani, O1
Al Dossari, M1
Alshahrani, A1
Alharbi, A1
Algarni, R1
Al Jeraisy, M1
Al Harbi, S1
Al Katheri, A1
Al Eidan, F1
Al Bekairy, AM1
Al Qahtani, N1
Al Muqrin, M1
Vishwakarma, R1
Al Ghamdi, G1

Reviews

3 reviews available for thiamine and 2019 Novel Coronavirus Disease

ArticleYear
MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.
    Expert review of anti-infective therapy, 2021, Volume: 19, Issue:2

    Topics: Anti-Inflammatory Agents; Anticoagulants; Ascorbic Acid; Clinical Protocols; COVID-19; COVID-19 Drug

2021
Could Vitamins Help in the Fight Against COVID-19?
    Nutrients, 2020, Aug-23, Volume: 12, Issue:9

    Topics: Antioxidants; Ascorbic Acid; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatm

2020
Clinical and Scientific Rationale for the "MATH+" Hospital Treatment Protocol for COVID-19.
    Journal of intensive care medicine, 2021, Volume: 36, Issue:2

    Topics: Ascorbic Acid; Clinical Protocols; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Hep

2021

Trials

1 trial available for thiamine and 2019 Novel Coronavirus Disease

ArticleYear
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Sexuality research & social policy : journal of NSRC : SR & SP, 2023, Apr-05

    Topics: Acute Kidney Injury; Adult; Aged; Albumins; Alloys; Amides; Amino Acids; Animals; Antineoplastic Com

2023

Other Studies

8 other studies available for thiamine and 2019 Novel Coronavirus Disease

ArticleYear
Biotin-thiamine responsive basal ganglia disease in the era of COVID-19 outbreak diagnosis not to be missed: A case report.
    Brain & development, 2022, Volume: 44, Issue:4

    Topics: Acute Febrile Encephalopathy; Basal Ganglia; Basal Ganglia Diseases; Biotin; Brain; Child, Preschool

2022
Addressing Cognitive Biases in Interpreting an Elevated Lactate in a Patient with Type 1 Diabetes and Thiamine Deficiency.
    Journal of general internal medicine, 2023, Volume: 38, Issue:6

    Topics: Beriberi; Bias; Cognition; COVID-19; Diabetes Mellitus, Type 1; Female; Humans; Lactic Acid; Pandemi

2023
GAYET WERNICKE'S ENCEPHALOPATHY AFTER COVID-19 IN ELDERLY SUBJECTS IN TROPICAL ENVIRONMENTS: STUDY OF SIX (6) OBSERVATIONS IN CONAKRY.
    Georgian medical news, 2023, Issue:334

    Topics: Aged; Brain Diseases; COVID-19; Guinea; Humans; Malnutrition; Pandemics; Thiamine; Wernicke Encephal

2023
The relationship between micronutrient status, frailty, systemic inflammation, and clinical outcomes in patients admitted to hospital with COVID-19.
    Journal of translational medicine, 2023, 04-28, Volume: 21, Issue:1

    Topics: COVID-19; Female; Frailty; Hospitals; Humans; Inflammation; Male; Micronutrients; Retrospective Stud

2023
Additional cost in personal protective equipment to NHS services during COVID-19: a review of the expense incurred by Aneurin Bevan Healthboards Maxillofacial unit over a one-year period to meet current clinical guidelines.
    The British journal of oral & maxillofacial surgery, 2020, Volume: 58, Issue:10

    Topics: COVID-19; Health Care Costs; Humans; Orthognathic Surgery; Personal Protective Equipment; SARS-CoV-2

2020
Relapse of rare diseases during COVID-19 pandemic: bicytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
    The Pan African medical journal, 2020, Volume: 35, Issue:Suppl 2

    Topics: Acute Coronary Syndrome; Anemia, Megaloblastic; Betacoronavirus; Chest Pain; Coronavirus Infections;

2020
[Multiple infectious cranial nerve palsies in COVID-19].
    Journal francais d'ophtalmologie, 2020, Volume: 43, Issue:10

    Topics: Adult; Ascorbic Acid; Azithromycin; Blepharoptosis; Central Nervous System Infections; COVID-19; Cra

2020
Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
    Critical care (London, England), 2021, 06-30, Volume: 25, Issue:1

    Topics: Adult; COVID-19; COVID-19 Drug Treatment; Critical Illness; Female; Hospital Mortality; Humans; Inte

2021